II
EW icon

IFM Investors’s Edwards Lifesciences EW Stock Holding History

IFM Investors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1M Buy
145,101
+11,761
+9% +$985K 0.09% 220
2026
Q1 		$10.7M Buy
133,340
+3,954
+3% +$326K 0.09% 211
2025
Q4 		$11M Buy
129,386
+4,769
+4% +$391K 0.09% 192
2025
Q3 		$9.5M Buy
124,617
+358
+0.3% +$28K 0.08% 217
2025
Q2 		$9.72M Buy
124,259
+2,930
+2% +$219K 0.09% 202
2025
Q1 		$8.79M Hold
121,329
– – 0.1% 207
2024
Q4 		$8.98M Sell
121,329
-11,220
-8% -$785K 0.09% 204
2024
Q3 		$8.75M Sell
132,549
-1,435
-1% -$104K 0.08% 234
2024
Q2 		$12.4M Buy
133,984
+189
+0.1% +$16.7K 0.13% 155
2024
Q1 		$12.8M Sell
133,795
-1,770
-1% -$149K 0.14% 148
2023
Q4 		$10.3M Buy
135,565
+2,792
+2% +$194K 0.13% 165
2023
Q3 		$9.2M Buy
132,773
+4,340
+3% +$349K 0.12% 170
2023
Q2 		$12.1M Buy
128,433
+4,031
+3% +$350K 0.16% 129
2023
Q1 		$10.3M Buy
124,402
+3,271
+3% +$257K 0.16% 130
2022
Q4 		$9.04M Buy
121,131
+11,801
+11% +$910K 0.15% 142
2022
Q3 		$9.03M Buy
109,330
+1,686
+2% +$162K 0.16% 127
2022
Q2 		$10.2M Buy
107,644
+5,084
+5% +$526K 0.18% 119
2022
Q1 		$12.1M Buy
102,560
+19,122
+23% +$2.15M 0.19% 104
2021
Q4 		$10.8M Buy
83,438
+224
+0.3% +$26.1K 0.2% 100
2021
Q3 		$9.42M Sell
83,214
-245
-0.3% -$28K 0.19% 102
2021
Q2 		$8.64M Buy
83,459
+13,886
+20% +$1.31M 0.18% 119
2021
Q1 		$5.82M Buy
69,573
+9,554
+16% +$808K 0.16% 132
2020
Q4 		$5.48M Buy
60,019
+8,834
+17% +$733K 0.17% 122
2020
Q3 		$4.09M Buy
51,185
+12,319
+32% +$961K 0.17% 123
2020
Q2 		$2.69M Sell
38,866
-22,817
-37% -$1.62M 0.14% 149
2020
Q1 		$4.03M Sell
61,683
-2,289
-4% -$165K 0.18% 124
2019
Q4 		$4.97M Sell
63,972
-3,315
-5% -$259K 0.18% 127
2019
Q3 		$4.93M Buy
67,287
+23,469
+54% +$1.65M 0.18% 125
2019
Q2 		$2.7M Buy
43,818
+3,267
+8% +$198K 0.15% 147
2019
Q1 		$2.59M Buy
40,551
+4,020
+11% +$229K 0.17% 137
2018
Q4 		$1.86M Buy
36,531
+3,258
+10% +$165K 0.15% 150
2018
Q3 		$1.93M Buy
33,273
+4,758
+17% +$233K 0.15% 150
2018
Q2 		$1.38M Buy
28,515
+8,961
+46% +$418K 0.13% 170
2018
Q1 		$909K Buy
19,554
+1,902
+11% +$82.6K 0.13% 174
2017
Q4 		$663K Buy
17,652
+165
+0.9% +$6.05K 0.1% 219
2017
Q3 		$637K Hold
17,487
– – 0.11% 221
2017
Q2 		$689K Buy
17,487
+4,353
+33% +$159K 0.12% 194
2017
Q1 		$412K Buy
13,134
+4,887
+59% +$153K 0.1% 227
2016
Q4 		$258K Buy
+8,247
New +$267K 0.12% 224

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

IFM Investors's EW Position: Q2 2026 in Review

IFM Investors increased its Edwards Lifesciences (EW) stake by 8.8% in Q2 2026, buying an estimated $985K and bringing the position to 145,101 shares worth $13.1M. The position accounts for 0.09% of the portfolio, ranked #220.

IFM Investors first reported a position in EW in Q4 2016 and has held it in 39 quarters since. 350 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • IFM Investors held 145,101 shares of Edwards Lifesciences worth $13.1M as of Q2 2026.
  • IFM Investors bought 11,761 Edwards Lifesciences shares in Q2 2026, an estimated $985K.
  • Edwards Lifesciences made up 0.09% of IFM Investors's portfolio in Q2 2026, its #220 holding.
  • IFM Investors first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 39 quarters since.
  • 350 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.